Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8366 USD | +0,04% | -7,96% | +46,77% |
Omzet 2024 * | - | Omzet 2025 * | 2,33 mln. 2,18 mln. | Marktkapitalisatie | 32,84 mln. 30,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -62 mln. -57,83 mln. | Nettowinst (verlies) 2025 * | -86 mln. -80,22 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 14,1 x |
K/w-verhouding 2024 * |
-0,72
x | K/w-verhouding 2025 * |
-0,75
x | Werknemers | 40 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,08% |
Recentste transcriptie over Viracta Therapeutics, Inc.
1 dag | -0,87% | ||
1 week | -7,96% | ||
Lopende maand | -17,98% | ||
1 maand | -21,08% | ||
3 maanden | +66,03% | ||
6 maanden | +27,78% | ||
Lopend jaar | +46,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 62 | 19-09-22 |
Melody Burcar
DFI | Director of Finance/CFO | 41 | 01-09-22 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01-10-07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01-02-21 |
Barry Simon
BRD | Director/Board Member | 69 | 03-03-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 0,8366 | +0,04% | 21 032 |
24-04-24 | 0,8363 | -1,36% | 55 057 |
23-04-24 | 0,8478 | -3,66% | 85 943 |
22-04-24 | 0,88 | +2,72% | 13 625 |
19-04-24 | 0,8567 | -5,75% | 52 615 |
uitgestelde koers Nasdaq, 25 april 2024 om 17:55 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,77% | 32,84 mln. | |
+0,91% | 43,84 mld. | |
+5,03% | 41,68 mld. | |
+45,26% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,06% | 25,53 mld. | |
-25,51% | 18,18 mld. | |
-3,19% | 12,29 mld. | |
+25,88% | 12,29 mld. | |
+7,09% | 11,15 mld. |